The trends of oral cavity and pharyngeal cancer incidence in Thailand, 2004-2015
Article Sidebar
Main Article Content
Abstract
The study of oral cavity and pharyngeal cancer incidence trends used report data of Cancer in Thailand of National Cancer Institute. The four reports presented the cancer during 2004-2006, 2007-2009, 2010-2012 and 2013-2015. During 2004-2006 to 2013-2015, males and females had increasing oral cavity cancer incidence from 4.8 to 5.5 and 3.6 to 4.3 persons per 100,000 population, respectively. Whereas pharyngeal cancer incidence slightly decreased in both genders. In the 2013-2015 duration, incidences of tongue and oropharyngeal cancer in males were higher than the past. Females had decreasing incidence rate of lip cancer. For incidence rate of oral cavity and pharyngeal cancer, males had nearly two times higher than females. Nasopharyngeal cancer in males had been reported in the youngest group (10-19 age group) while lip cancer in females was found at 0-5 age group, which rapidly increased when older than 50 years. Oropharyngeal and hypopharyngeal cancer in females also found at 40-44 age group. Tongue, mouth and salivary gland in both male and female were found at 20-29 age group. Since the incidence rate of all site-cancers positively increased with older age and cancer of some sites still had high incidence, efficient oral screening and referral are important to early detection and access the treatment. The age groups having the highest incidence rate among organ sites according to risk behavior should be considered as specific age group for oral screening.
Downloads
Article Details
References
2. Argirion I, Zarins KR, Defever K, Suwanrungruang K, Chang JT, Pongnikorn D. Temporal changes in head and neck cancer incidence in Thailand suggest changing oropharyngeal epidemiology in the region. J Glob Oncol 2019 Mar; 5:1-11.
3. Morse DE, Psoter WJ, Cleveland D, Cohen D, Mohit-Tabatabai M, Kosis DL, Eisenberg F. Smoking and drinking in relation to oral cancer and oral epithelial dysplasia. Cancer Causes Control 2007; 18(9):919-29.
4. Sadri G, Mahjub H. Tobacco smoking and oral cancer: a meta-analysis. J Res Health Sci 2007; 7(1):18-23.
5. Barnes JL, Zubair M, John K, Poirier MC, Martin FL. Carcinogens and DNA damage. Biochem Soc Trans 2018; 46(5):1213-24.
6. Schaal C, Chellappan SP. Nicotine-mediated cell proliferation and tumor progression in smoking-related cancers. Mol Cancer Res. 2014; 12(1):14-23.
7. Hecht SS, Stepanov I, Carmella SG. Exposure and metabolic activation biomarkers of carcinogenic tobacco-specific nitrosamines. Acc Chem Res 2016; 49(1):106-14.
8. Montesano R. Alkylation of DNA and tissue specificity in nitrosamine carcinogenesis. J Supramol Struct Cell Biochem 1981; 17(3):259-73.
9. Chen PH, Mahmood Q, Mariottini GL, Chiang TA, Lee KW. Adverse health effects of betel quid and the risk of oral and pharyngeal cancers. Biomed Res Int 2017; 2017:3904098.
10. Tsou HH, Ko HT, Chen CT, Wang TW, Lee CH, Liu TY, Wang HT. Betel quid containing safrole enhances metabolic activation of tobacco specific 4-(methylnitrosamino)-1-(3-pyridyl)-1-bu tanone (NNK). Environmental Pollution 2019; 251:13-21.
11. Gallagher RP, Lee TK, Bajdik CD, Borugian M. Ultraviolet radiation. Chronic Dis Can 2010; 29 Suppl 1:51-68.
12. Busick TL, Uchida T, Wagner RF Jr. Preventing ultraviolet light lip injury: beachgoer awareness about lip cancer risk factors and lip protection behavior. Dermatol Surg 2005; 31(2):173-6.
13. You EL, Henry M, Zeitouni AG. Human papilloma virus–associated oropharyngeal cancer: review of current evidence and management. Curr Oncol 2019; 26(2):119–23.
14. Eisenberg MC, Campredon LP, Brouwer AF, Walline HM, Marinelli BM, Lau YK, et al. Dynamics and determinants of HPV infection: The Michigan HPV and oropharyngeal cancer (M-HOC) study. BMJ Open 2018; 8(10):e021618.
15. Candotto V, Lauritano D, Nardone M, Baggi L, Arcuri C, Gatto R, et al. HPV infection in the oral cavity: epidemiology, clinical manifestations and relationship with oral cancer. Oral Implantol (Rome) 2017; 10(3):209–20.
16. Hearnden V, Murdoch C, D’Apice K, Duthie S, Hayward NJ, Powers HJ. Oral human papillomavirus infection in England and associated risk factors: a case–control study. BMJ Open 2018; 8:e022497.
17. Tsao SW, Tsang CM, Lo KW. Epstein-Barr virus infection and nasopharyngeal carcinoma. Phil. Trans R Soc 2017; B372: 20160270.
18. Novacek G. Plummer-Vinson syndrome. Orphanet J Rare Dis 2006, 1:36.
19. National Statistic Office. Smoking and alcohol drinking behavior survey 2017. Bangkok; Pimdeekarnpim Co., Ltd. 2018. (in Thai)
20. World Health Organization. International statistical classification of diseases and related health problems. The 10th revision, 5th edition, 2016.
21. Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG. Cancer registration: Principles and methods. IARC: Lyon, France; 1991.
22. Brown LM, Check DP, Devesa SS. Oral cavity and pharynx cancer incidence trends by subsite in the United States: changing gender patterns. J Oncol 2012; 2012: 649498.
23. Bruni L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J, Bosch FX, de Sanjosé S. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report 17 June 2019.
24. Sankaranarayanan R, Ramadas K, Thomas G, Muwonge R, Thara S, Mathew B, Rajan B. Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial. Journal of Global Oncology 2005; 365(9475):1927-33.
25. Seenuanlae L, Vatanasapt P, Promthet S, Kamsa-ard S. Five Years Survival of Oral Cavity Cancer Squamous Cell Carcinoma Type in Srinagarind Hospital, Khon Kaen University. KKU KKU-JPHR 2013; 6(1): 61-70. (in Thai)
26. Ayan I, Kaytan E, Ayan N. Childhood nasopharyngeal carcinoma: from biology to treatment. The Lancet Oncology 2003; 4(1):13-21.
27. Moyer VA. Screening for oral cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014; 160(1): 55–60.
28. Mabry-Hernandez I, Chu K. Screening for Oral Cancer. Am Fam Physician 2015; 91(6): 387-8.
29. Chuang SL, Su WW, Chen SL, Yen AM, Wang CP, Fann JC, et al. Population-based screening program for reducing oral cancer mortality in 2,334,299 Taiwanese cigarette smokers and/or betel quid chewers. Cancer 2017; 123(9):1597-609.
30. Nagao T, Warnakulasuriya S. Annual screening for oral cancer detection. Cancer Detect Prev 2003; 27(5):333-7.